“COMPARATIVE PHARMACOECONOMIC EVALUATION OF THE USE OF AFATINIB AND GEFITINIB IN THERAPY FOR LUNG CANCER”. Voprosy Onkologii, vol. 63, no. 1, Jan. 2017, pp. 38-51, https://doi.org/10.37469/0507-3758-2017-63-1-38-51.